OpenAlex
PricingAboutJobs
Log inGet started
Work

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial

HTML

Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(14)70036-1
Authors: Peter J Hoskin, Amy A Kirkwood, Bilyana Popova, Paul Smith, Martin Robinson, Eve Gallop-Evans, Stewart Coltart, Timothy Illidge, Krishnaswamy Madhavan, Caroline Brammer, Patricia Diez, Andrew Jack, Isabel Syndikus
Institutions: Mount Vernon Cancer Centre, Cancer Research UK, University College London, Weston Park Cancer Centre, Velindre Cancer Centre, Kent and Canterbury Hospital, The Christie Hospital, Southend Hospital, New Cross Hospital, Leeds General Infirmary, Clatterbridge Cancer Centre NHS Foundation Trust
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: follicular lymphoma, marginal zone lymphoma, indolent lymphoma, radiotherapy dose, hypofractionated radiotherapy, dose-response relationship, local progression, non-inferiority, acute toxicity, late toxicity, mucositis, palliative radiotherapy, definitive radiotherapy
SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Research UK
Awards: G1737400705, G4051342387
OpenAlex ID: W1987270559
FWCI: 14.17
Cites: 9
Cited by: 261
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms